{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:28:47Z","timestamp":1793744927238,"version":"4.6.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,1,1]],"date-time":"2027-01-01T00:00:00Z","timestamp":1798761600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003761","name":"University Medical Centre Utrecht","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ctro.science","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical and Translational Radiation Oncology"],"published-print":{"date-parts":[[2027,1]]},"DOI":"10.1016\/j.ctro.2026.101297","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T16:54:21Z","timestamp":1790096061000},"page":"101297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["MR-guided ultra-hypofractionated radiotherapy for early-stage glottic cancer: A phase I feasibility study"],"prefix":"10.1016","volume":"62","author":[{"given":"S.M.L.","family":"Linden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.P.","family":"Philippens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Rijken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Brand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.M.C.","family":"Schoenmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.P.J.","family":"Raaijmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.P.W.","family":"Intven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"de Ridder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ctro.2026.101297_bb0005","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.radonc.2016.02.006","article-title":"Pattern of failure in 5001 patients treated for glottic squamous cell carcinoma with curative intent \u2013 a population based study from the DAHANCA group","volume":"118","author":"Lyhne","year":"2016","journal-title":"Radiother. Oncol."},{"issue":"8","key":"10.1016\/j.ctro.2026.101297_bb0010","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1002\/hed.70245","article-title":"Early-stage glottic squamous cell carcinoma: a Nationwide analysis on incidence, survival, recurrences, and laryngectomies after radiotherapy in the Netherlands (2015\u20132021)","volume":"48","author":"Linden","year":"2026","journal-title":"Head Neck"},{"key":"10.1016\/j.ctro.2026.101297_bb0015","article-title":"Risk of dysfunctional larynx after radiotherapy for early-stage glottic laryngeal cancer: a systematic review and meta-analysis","volume":"214","author":"Linden","year":"2025","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.ctro.2026.101297_bb0020","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijrobp.2024.07.2147","article-title":"Stereotactic ablative radiotherapy for T1 to T2 glottic larynx cancer: mature results from the phase 2 GLoTtic larynx-SABR trial","volume":"121","author":"Sher","year":"2025","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ctro.2026.101297_bb0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ijrobp.2024.09.051","article-title":"Stereotactic radiation therapy in 3 fractions for T1 glottic Cancer","volume":"121","author":"Sanguineti","year":"2025","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"9","key":"10.1016\/j.ctro.2026.101297_bb0030","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1002\/hed.28139","article-title":"Ultra-Hypofractionated radiotherapy for early-stage glottic Cancer: real-world data from a single Center","volume":"47","author":"Gundog","year":"2025","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.ctro.2026.101297_bb0035","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijrobp.2019.03.011","article-title":"Early closure of a phase 1 clinical trial for SABR in early-stage glottic cancer","volume":"105","author":"Kang","year":"2019","journal-title":"Int. J. Rad. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ctro.2026.101297_bb0040","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijrobp.2019.03.010","article-title":"Phase 1 fractional dose-escalation study of equipotent stereotactic radiation therapy regimens for early-stage glottic larynx cancer","volume":"105","author":"Sher","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"2","key":"10.1016\/j.ctro.2026.101297_bb0045","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0360-3016(98)00226-0","article-title":"The impact of treatment time and smoking on local control and complications in T1 glottic cancer","volume":"42","author":"van der Voet","year":"1998","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.ctro.2026.101297_bb0050","article-title":"Treatment time and learning curve analysis of 1.5 T MR-Linac workflows led by radiation oncologists or therapists","volume":"51","author":"Westerhoff","year":"2025","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"10.1016\/j.ctro.2026.101297_bb0055","first-page":"31","article-title":"Development and results of a patient-reported treatment experience questionnaire on a 1.5 T MR-Linac","volume":"30","author":"Barnes","year":"2021","journal-title":"Clin. Transl. Radiat. Oncol."},{"issue":"3","key":"10.1016\/j.ctro.2026.101297_bb0060","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1044\/1058-0360.0603.66","article-title":"The voice handicap index (VHI)","volume":"6","author":"Jacobson Barbara","year":"1997","journal-title":"Am. J. Speech Lang. Pathol."}],"container-title":["Clinical and Translational Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405630826001928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T22:03:59Z","timestamp":1793743439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405630826001928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,1]]},"references-count":12,"alternative-id":["S2405630826001928"],"URL":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101297","relation":{},"ISSN":["2405-6308"],"issn-type":[{"value":"2405-6308","type":"print"}],"subject":[],"published":{"date-parts":[[2027,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MR-guided ultra-hypofractionated radiotherapy for early-stage glottic cancer: A phase I feasibility study","name":"articletitle","label":"Article Title"},{"value":"Clinical and Translational Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctro.2026.101297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Society for Radiotherapy and Oncology.","name":"copyright","label":"Copyright"}],"article-number":"101297"}}